Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors

Bioorg Med Chem. 2015 Aug 1;23(15):4508-4513. doi: 10.1016/j.bmc.2015.06.014. Epub 2015 Jun 14.

Abstract

Therapies based on urease inhibition are now seriously considered as the first line of treatment for infections caused by Helicobacter pylori. However, the present inhibitors are ineffective or unstable in highly acidic gastric juice. Here, we report a series of benzylanilines as effective inhibitors of H. pylori urease. Out of the obtained twenty-one compounds, N-(3,4-dihydroxybenzyl)-4-nitroaniline (4) was evaluated in detail and shows promising features for development as anti-H. pylori agent. Excellent potency against urease in both cell-free extract and intact cell was observed at low concentrations of 4 (IC50=0.62 ± 0.04 and 1.92 ± 0.09 μM), which showed over 29- and 54-fold increase in potency with respect to the positive control AHA. The SAR analysis revealed that protection of 3,4-dihydroxy group of 4 as methoxy or changes of 4-NO2 will result in a moderate to dramatic decrease in potency.

Keywords: Benzylaniline; Molecular docking; Peptic ulcer; Urease inhibitor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Enzyme Inhibitors / chemical synthesis*
  • Enzyme Inhibitors / pharmacology*
  • Ethane / analogs & derivatives*
  • Ethane / chemical synthesis
  • Ethane / pharmacology
  • Helicobacter pylori / enzymology*
  • Molecular Docking Simulation
  • Structure-Activity Relationship
  • Urease / antagonists & inhibitors*

Substances

  • Enzyme Inhibitors
  • Urease
  • Ethane